Neophar Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Delhi, Delhi, India, established in 2023.
2023 Delhi, Delhi, India Active
Last Updated:
Access Report
About Neophar Pharmaceuticals Private Limited

Neophar Pharmaceuticals Private Limited, a active private limited company, was established on 19 October 2023 in Delhi, Delhi, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21001DL2023PTC421633. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Manish Kumar (Director), Ruby Rani (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No 221, Ground Floor, Pkt H, Sector-1, Bawana, Delhi, Delhi, Delhi, 110039.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001DL2023PTC421633

  • Registration Number

    421633

  • Incorporation Date

    19 October 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Neophar Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neophar Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neophar Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Manish Kumar Director 19 Oct 2023 Current
Ruby Rani Director 19 Oct 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neophar Pharmaceuticals.

Enhance accessibility to Neophar Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Neophar Pharmaceuticals revenue growth over time
Neophar Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neophar Pharmaceuticals?

Unlock access to Neophar Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neophar Pharmaceuticals?

Unlock and access historical data on people associated with Neophar Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neophar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neophar Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neophar Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Neophar Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Neophar Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Director Appointment

    The activity Manish Kumar was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    Ruby Rani was appointed as a Director was appointed as a Director on 19 Oct 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Neophar Pharmaceuticals Private Limited was registered on 19 Oct 2023 with Roc Delhi & aged 2 years 4 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neophar Pharmaceuticals Private Limited?

The CIN of Neophar Pharmaceuticals Private Limited is U21001DL2023PTC421633.

Where is Neophar Pharmaceuticals Private Limited headquartered?

Neophar Pharmaceuticals Private Limited is headquartered at Plot No 221, Ground Floor, Pkt H, Sector-1, Bawana, Delhi, Delhi, Delhi, 110039.

When was Neophar Pharmaceuticals Private Limited incorporated?

Neophar Pharmaceuticals Private Limited was incorporated on 19 October 2023.

Who are the current directors of Neophar Pharmaceuticals Private Limited?

The current directors of Neophar Pharmaceuticals Private Limited are

What is the primary industry of Neophar Pharmaceuticals Private Limited?

The primary industry of Neophar Pharmaceuticals Private Limited is Paper.

Is Neophar Pharmaceuticals Private Limited a listed company?

Neophar Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Neophar Pharmaceuticals Private Limited?

The authorized capital of Neophar Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available